Iolyx Therapeutics

Developer of therapeutics for autoimmunity and ophthalmological conditions

placeBurlingame, California, United States calendar_todayFounded 2019 language iolyx.com

Registered entities

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon